The invention relates to a pharmaceutical tablet for oral administration comprising ulipristal acetate together with the following excipients: at least one diluent in an amount of 50 to 98.5 wt%, at least one binding agent in an amount of 0 to 10 wt%, at least one disintegrating agent in an amount of 0.5 to 10 wt%, and at least one lubricant in an amount of 0 to 10 wt%.
申请公布号
WO2010066749(A3)
申请公布日期
2010.08.05
申请号
WO2009EP66652
申请日期
2009.12.08
申请人
LABORATOIRE HRA PHARMA;GAINER, ERIN;GUILLARD, HELENE;GICQUEL, DENIS;HENRION, MARIANNE;GNAKAMENE, CELINE